logo

Intellia Therapeutics Inc (NTLA) Stock: A Year of Highs and Lows in the Market

ELVT Stock

The 52-week high and low prices can offer valuable insights into a stock’s current standing and prospects for future performance. Intellia Therapeutics Inc’s current trading price is -71.75% away from its 52-week high, while its distance from the 52-week low is 2.76%. The stock’s price range for this period has been between $9.59 and $34.87 The company’s shares, which are part of the Healthcare sector, had a trading volume of approximately 1.3 million for the day, a number notably lower than the average daily volume of 2.83 million over the last three months.

Intellia Therapeutics Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $34.87 on 02/29/24, while the lowest price for the same period was registered at $9.59 on 01/14/25.

Exploring Financial Performance and Market Capitalization: A Comprehensive Analysis

Intellia Therapeutics Inc (NTLA) has experienced a quarterly decline of -49.51% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 1.00B and boasts a workforce of 526 employees.

Analyzing Trading Volume and Moving Average Trends

Based on Barchart.com data, the company’s moving average over the 100-day period was 16.85, with a change in price of -13.68. Similarly, Intellia Therapeutics Inc recorded 2,315,046 in trading volume during the last 100 days, posting a change of -57.94%.

Understanding Ticker ‘s Debt-to-Equity Ratio: An Analysis

The debt-to-equity (D/E) ratio serves as an important indicator of a company’s financial stability and market position. By dividing a company’s total liabilities by its shareholders’ equity, the D/E ratio reveals the degree to which a company relies on debt to finance assets compared to its shareholders’ equity. At the time of writing, the total D/E ratio for NTLA stands at 0.11. Similarly, the long-term debt-to-equity ratio is also 0.09.

NTLA Stock Stochastic Average

Intellia Therapeutics Inc’s raw stochastic average for the past 50 days is presently 4.18%, as of today. This marks a decrease from the raw stochastic average of the last 20 days, which was 8.20%. Additionally, the company’s Stochastic %K and %D values for the past 20 days were 6.95% and 8.08%, respectively.

NTLA Stock Price Performance Analysis

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. The index has shown a price loss of -15.52% this year. Over the last six months, there has been a stronger performance of -63.99%. The price of NTLA leaped by -27.36% during the last 30 days period. For the last 5-days stocks have slided -21.01%.

Most Popular